New clinical trial evidence from Pennsylvania State University indicates that adopting a Mediterranean-style diet, even with moderate lean beef consumption, improves metabolic and gut health more effectively than a standard American diet. Published in the Journal of the American Heart Association, the study highlights the overarching importance of dietary quality.
Excessive red meat consumption is linked to increased cardiovascular risk, primarily due to elevated levels of trimethylamine N‐oxide (TMAO), a metabolite associated with atherosclerosis. While beef intake is often tied to higher TMAO production, recent studies suggest that lean meat within heart-healthy diets does not elevate conventional cardiovascular risk factors.
The Dietary Guidelines for Americans recommend 737 grams of meats, poultry, and eggs weekly for a 2,000-kcal diet. In contrast, Mediterranean diets with up to 500 grams of red meat weekly have shown increased TMAO compared to lower consumption levels. Researchers at Pennsylvania State University conducted a four-period crossover trial to assess the effects of varying lean beef amounts within a Mediterranean diet on gut health and metabolic outcomes.
The trial involved three Mediterranean diets with 14, 71, and 156 grams of lean beef per day, compared to an American diet with 71 grams per day. Thirty healthy participants followed each diet for four weeks, with data collected at baseline and post-diet periods. Greek yogurt in the Mediterranean diets contributed to observed microbial differences.
Results revealed that Mediterranean diets with 14 or 71 grams of lean beef enhanced gut microbiota diversity and reduced TMAO levels more effectively than the American diet. Notably, the 156-gram Mediterranean diet did not significantly impact diversity, indicating that higher lean beef intake does not necessarily increase TMAO levels.
The study suggests that a Mediterranean diet, rich in plant-based foods and fibre, may limit TMAO production by shaping gut microbiota, even with increased lean beef consumption. Despite higher blood carnitine levels, a TMAO precursor, in Mediterranean diets, this did not translate to elevated TMAO production, challenging assumptions about red meat’s impact on cardiovascular health.
Participants consistently showing higher TMAO levels also had greater gut microbiota diversity, underscoring the complexity of diet-microbiota interactions. While the study did not observe diet-induced shifts in microbial functional pathways, it highlights limitations in predictive microbial analyses.
Conducted on metabolically healthy individuals, the study’s applicability to those with metabolic disorders is limited. Additionally, the American diet’s higher fibre content compared to typical intake may affect comparisons. Ultimately, the findings advocate for healthy dietary patterns’ role in modulating gut microbiota and suggest that moderate lean beef in a Mediterranean diet does not elevate TMAO-related cardiovascular risk.
